Loading song details...
Durvalumab Plus Bevacizumab Added To TACE Shows Benefit For Unresectable Hepatocellular Carcinoma
No description available.
MP3 Download
Video Download
Related Songs
7:23
Durvalumab Plus Bevacizumab Added To TACE Shows Benefit For Unresectable Hepatocellular Carcinoma
0:51
EMERALD 1 Trial Improved PFS W Durvalumab Bevacizumab TACE Vs In Hepatocellular Carcinoma
0:55
Exploring Durvalumab Bevacizumab TACE In Hepatocellular Carcinoma EMERALD 1 Insights
1:34
EMERALD 1 Durvalumab Bevacizumab And TACE In Unresectable HCC
2:09
Safey Findings Of EMERALD 1 Durvalumab Bevacizumab And TACE In HCC
2:25
Imfinzi Durvalumab Plus Bevacizumab Met Endpoints In EMERALD 1 Phase III Results Liver Cancer
1:32
Comparing Atezolizumab Bevacizumab With STRIDE In Advanced HCC
1:03
Phase III EMERALD 1 Bevacizumab And Durvalumab With TACE Improves PFS In Unresectable HCC
1:07
Dr Balar On Impact Of Durvalumab Plus Tremelimumab In Bladder Cancer
44:01
Webinar Combination Of Durvalumab Bevacizumab Tremelimumab Transarterial Chemoembolization
1:08
First Line Durvalumab Monalizumab In Microsatellite Stable CRC
1:43
Durvalumab For NMIBC What You Need To Know
3:38
EMERALD 1 Trial In HCC
2:26
Durvalumab BCG Bladder Cancer Breakthrough
1:06
Sequencing Treatment Options For HCC
6:38
From Frontline To Adjuvant Dr Laura Goff On The Expanding Role And Limits Of Immunotherapy In HCC
0:41
Therapeutic Challenges In HCC Individualizing Treatment Decisions
3:16
Phase 1b Trial Of Durvalumab Plus Tremelimumab For Advanced Non Small Cell Lung Cancer
4:31
Durvalumab Addtion To Chemo Shows Endometrial Cancer Benefit
4:21